Adaptive Technology (Europe) Limited

adaptivetechnology.eu

ATEL are at the forefront of Universal Design and Smart Living offering a full range of solutions to people with learning disabilities, physical disabilities, complex needs and behaviour which challenges within a supported living environment as well as Extra Care housing.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech, Industry Outlook

IPA'S SUBSIDIARY, BIOSTRAND, SOLVES THE INFORMATION INTEGRATION DILEMMA (IID) FOR SYSTEMS BIOLOGY

Businesswire | May 31, 2023

news image

ImmunoPrecise Antibodies Ltd. an AI-driven biotherapeutic research and technology company, announced that its subsidiary, BioStrand®, has successfully solved the Information Integration Dilemma (IID) by developing a unique technology design that enables their patented HYFT Technology to encapsulate and unify diverse data modalities - including syntactical (sequence) data, 3D structural data, unstructured scientific information (e.g. scientific literature), and beyond - into a singular,...

Read More

Cell and Gene Therapy

DISCOVERY LIFE SCIENCES LAUNCHES GMP COMPLIANT DISCOVERY LEUKOPAKS™ TO ACCELERATE RESEARCH AND DEVELOPMENT OF CELL AND GENE THERAPIES

Discovery Life Sciences | October 28, 2020

news image

Discovery Life Sciences™ (Discovery), a global leader in biospecimen, genomic sequencing, cell, and immunohistochemistry (IHC) services, announces the launch of GMP-compliant Discovery Leukopaks™ and other cell-based products for use in human cell and gene therapy research, development and manufacturing programs. Cell and gene therapies have revolutionized treatment approaches to cancer and other complex diseases. Acceleration of the manufacturing and development of these novel thera...

Read More

Medical, Industry Outlook

TRIRX PARTNERSHIP WITH LIVERPOOL CITY REGION ADVANCES BIOTECH CAPABILITIES

PRNewswire | July 31, 2023

news image

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization (CDMO), welcomed the UK Government's recent announcement on England's second Investment Zone, focused on Life Sciences in the Liverpool City Region. TriRx Speke Ltd. is the first investor and is well-positioned to further advance its capabilities by adding upstream technologies to manufacture monoclonal antibodies to an existing large-scale biotech purification facility. The current...

Read More

Industrial Impact, Medical

MOLECULAR ASSEMBLIES DELIVERS FIRST ENZYME-SYNTHESIZED OLIGONUCLEOTIDES

Molecular Assemblies, Inc. | March 15, 2023

news image

On March 14, 2023, Molecular Assemblies, Inc., a leading life sciences company, made a significant announcement regarding its enzymatic DNA synthesis technology. The company has successfully shipped the first enzymatically synthesized oligonucleotides to leading researchers in biotechnology, academic, and synthetic biology. The capacity to synthesize lengthy, extremely pure DNA promptly utilizing a proprietary Fully Enzymatic Synthesis (FES) technology solves critical unmet demands in DNA ...

Read More
news image

MedTech, Industry Outlook

IPA'S SUBSIDIARY, BIOSTRAND, SOLVES THE INFORMATION INTEGRATION DILEMMA (IID) FOR SYSTEMS BIOLOGY

Businesswire | May 31, 2023

ImmunoPrecise Antibodies Ltd. an AI-driven biotherapeutic research and technology company, announced that its subsidiary, BioStrand®, has successfully solved the Information Integration Dilemma (IID) by developing a unique technology design that enables their patented HYFT Technology to encapsulate and unify diverse data modalities - including syntactical (sequence) data, 3D structural data, unstructured scientific information (e.g. scientific literature), and beyond - into a singular,...

Read More
news image

Cell and Gene Therapy

DISCOVERY LIFE SCIENCES LAUNCHES GMP COMPLIANT DISCOVERY LEUKOPAKS™ TO ACCELERATE RESEARCH AND DEVELOPMENT OF CELL AND GENE THERAPIES

Discovery Life Sciences | October 28, 2020

Discovery Life Sciences™ (Discovery), a global leader in biospecimen, genomic sequencing, cell, and immunohistochemistry (IHC) services, announces the launch of GMP-compliant Discovery Leukopaks™ and other cell-based products for use in human cell and gene therapy research, development and manufacturing programs. Cell and gene therapies have revolutionized treatment approaches to cancer and other complex diseases. Acceleration of the manufacturing and development of these novel thera...

Read More
news image

Medical, Industry Outlook

TRIRX PARTNERSHIP WITH LIVERPOOL CITY REGION ADVANCES BIOTECH CAPABILITIES

PRNewswire | July 31, 2023

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization (CDMO), welcomed the UK Government's recent announcement on England's second Investment Zone, focused on Life Sciences in the Liverpool City Region. TriRx Speke Ltd. is the first investor and is well-positioned to further advance its capabilities by adding upstream technologies to manufacture monoclonal antibodies to an existing large-scale biotech purification facility. The current...

Read More
news image

Industrial Impact, Medical

MOLECULAR ASSEMBLIES DELIVERS FIRST ENZYME-SYNTHESIZED OLIGONUCLEOTIDES

Molecular Assemblies, Inc. | March 15, 2023

On March 14, 2023, Molecular Assemblies, Inc., a leading life sciences company, made a significant announcement regarding its enzymatic DNA synthesis technology. The company has successfully shipped the first enzymatically synthesized oligonucleotides to leading researchers in biotechnology, academic, and synthetic biology. The capacity to synthesize lengthy, extremely pure DNA promptly utilizing a proprietary Fully Enzymatic Synthesis (FES) technology solves critical unmet demands in DNA ...

Read More

Resources

resource image

Cell and Gene Therapy, Industrial Impact

Single-cell RNA Sequencing and Analysis

Video

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy, MedTech

Multi-Specific Monoclonal Antibodies

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

Single-cell RNA Sequencing and Analysis

Video

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy, MedTech

Multi-Specific Monoclonal Antibodies

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us